Isotretinoin-induced psychosis in a child on treatment for high-risk neuroblastoma

被引：0
|
作者：
Greenwell, Alyssa M. M. [1 ,3 ]
Gorsi, Hamza S. S. [1 ,2 ]
机构：
[1] Childrens Hosp Michigan, Dept Hematol Oncol, Detroit, MI USA
[2] Cent Michigan Univ, Sch Med, Mt Pleasant, MI USA
[3] Childrens Hosp Michigan, Pediat GME Off, 3901 Beaubien, Detroit, MI 48201 USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷 / 04期
关键词：
D O I：
10.1002/pbc.30142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Oxytocin as a treatment for high-risk psychosis or early stages of psychosis: a mini review
    Bargiota, Stavroula I.
    Papakonstantinou, Anna V.
    Christodoulou, Nikolaos G.
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [22] Radiation-induced lymphopenia in pediatric high-risk neuroblastoma
    Gomis Selles, E.
    Munoz Munoz, O.
    Delgado Leon, B. D.
    Cabrera Roldan, P.
    Burgueno Caballero, A. M.
    Lopez Guerra, J. L.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1273 - S1274
  • [23] Detection and treatment of minimal residual disease in high-risk neuroblastoma
    Reynolds, CP
    PEDIATRIC TRANSPLANTATION, 2004, 8 : 56 - 66
  • [24] Treatment of High-Risk Neuroblastoma: Experience of Russian Federal Centers
    Kachanov, D.
    Shamanskaya, T.
    Andreev, E.
    Talypov, S.
    Khismatullina, R.
    Shevtsov, D.
    Skorobogatova, E.
    Kirgizov, K.
    Hachatryan, L.
    Roschin, V.
    Olshanskaya, Y.
    Kazakova, A.
    Shcherbakov, A.
    Tereschenko, G.
    Nechesnyuk, A.
    Grachev, N.
    Fomin, D.
    Maschan, M.
    Likar, Y.
    Varfolomeeva, S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S197 - S197
  • [25] Bronchiectasis following treatment for high-risk neuroblastoma: A case series
    Adams, Madeleine
    Traunecker, Heidi
    Doull, Iolo
    Cox, Rachel
    PEDIATRIC BLOOD & CANCER, 2017, 64 (10)
  • [26] EVALUATION OF THE ATHEROGENIC RISK OF ISOTRETINOIN-INDUCED AND ETRETINATE-INDUCED ALTERATIONS OF LIPOPROTEIN CHOLESTEROL-METABOLISM
    MELNIK, BC
    BROS, U
    PLEWIG, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 88 (03) : S39 - S43
  • [27] OXALIPLATIN AND DOXORUBICIN TREATMENT FOR RELAPSED AND REFRACTORY HIGH-RISK NEUROBLASTOMA
    Hung Tran
    Marachelian, Araz
    Venkatramani, Rajkumar
    Jubran, Rima
    Mascarenhas, Leo
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S73 - S73
  • [28] Interest in the autologous graft pruge in the treatment of high-risk neuroblastoma
    Marabelle, A.
    Kanold, J.
    Derneocq, F.
    Rousseau, R.
    Merlin, E.
    Halle, P.
    BULLETIN DU CANCER, 2008, 95 : S66 - S66
  • [29] DEGRADATION OF XIAP AS A NOVEL TREATMENT STRATEGY IN HIGH-RISK NEUROBLASTOMA
    Choo, Zhang'E
    Wong, Megan
    Ahamed, Nurul Ali
    Kang, Congbao
    Kuick, Chik Hong
    Chang, Kenneth
    Larisch, Sarit
    Loh, Amos
    Chen, Zhi Xiong
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S318 - S318
  • [30] The safety of dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma
    Greenwood, Katie L.
    Foster, Jennifer H.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1257 - 1262
12345